The Magazine for Sleep Professionals
Thursday, July 23, 2026
Inspire Medical Systems, Inc. is providing an update on the 2022 Reimbursement payment rates for Inspire procedures performed in Ambulatory Surgical Centers (ASCs). The Centers for Medicare and Medicaid Services (CMS) today published updated addendum files for the 2022 ASC payment system, including updating the assigned device offset percentage and […]
Sommetrics, a private company developing products and services to improve sleep health, has announced its lead sleep apnea product, aerSleep II, has received FDA Breakthrough Device designation. This program allows for additional FDA feedback to sponsors during the pre-marketing phase but does not alter the basic requirements for market authorization. […]
Lune, a holistic training and monitoring system for people with sleep apnea trouble, encourages a sound sleep by stimulating oral muscles around the throat by means of pulsating electrodes. Inspired by the male frog’s mate calling technique, which is when the male frog lifts his head upwards in order to […]
Inspire Medical Systems, Inc. (“Inspire”) announced today that Cigna, one of the leading health plans in the United States, will provide coverage for the Company’s Inspire therapy (hypoglossal nerve neurostimulation), effective June 15, 2020. Cigna Corporation is a global health service company that provides health insurance coverage for approximately 16 […]
Bongo Rx, an FDA cleared medical device for the treatment of mild to moderate obstructive sleep apnea, utilizes no electricity or batteries. This cutting edge medical technology reduces the carbon footprint in the battle against global warming as no fossil fuels are consumed to power the device during use. […]
According to a recent Qualtrics Survey conducted September 4th through September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice. The Bongo […]
The AirAvant Medical team is looking forward to sharing their poster findings with the attendees at the SLEEP 2019 conference in San Antonio on June 8-12. The opportunity to engage with industry experts, doctors, and providers is sure to generate even more clinical interest in using the Bongo Rx, an […]
AirAvant Medical is proud to announce that its flagship product, FDA Cleared Bongo Rx, is now available for patients requiring treatment of mild to moderate obstructive sleep apnea (OSA). Years of painstaking research, development, and testing have yielded a device that is small, portable, and best of all requires no […]
